Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Bedwetting Knowledge Centre What's New

    Launch of the Updated Bedwetting
    Knowledge Centre

    The Bedwetting Knowledge Centre has been given a fresh new look with a
    mobile-responsive design. Users will be better able to use their mobile devices
    to explore sections on disease awareness, publication summaries and a case
    study-led CME activity with ease. Ensure you 
    return to visit this resource often
    to avoid missing out on a number of upcoming content 

  • ,What's New Thrombosis Educational Portal

    Thrombosis Educational Portal (Advertorial)

    Containing sections on thrombosis, venous thromboembolism (VTE) prevention and
    treatment, atrial fibrillation, acute coronary syndrome (ACS) and quarterly-updated
    newsletters, the Thrombosis Educational Portal provides healthcare professionals
    with links to a comprehensive resource used in the treatment and management
    of venous and arterial thrombosis.

  • ,

    Launch of ‘IL-17A in Psoriasis’ section

    Located within the Psoriasis Knowledge Centre is a new IL-17A in Psoriasis
    educational area. This resource has been developed primarily to discuss the role
    of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential
    of treatments directed towards IL-17A. Users will find expert videos, clinical
    presentations on topics such as disease perception and emerging therapies, congress
    highlights, key publications and useful resources.

    This resource has been developed in collaboration with Novartis Pharma AG.

  • ,

    Launch of Obesity Learning Hub

    A learning hub has recently launched on epgonline.org offering comprehensive
    information on obesity. Healthcare professionals now have free access to the
    Knowledge Centre, EACCME-accredited European Obesity Initiative CME series
    and a range of additional resources including events information, news and
    journal articles, a clinical media library and patient guides.

  • ,What's New CLL

    Symptomatic Asthma Learning Zone

    A new educational resource for healthcare professionals involved in treating patients with
    symptomatic asthma has launched on epgonline.org. This resource contains a disease
    awareness section with information on symptom control, treatment recommendations and
    the GINA assessment of current clinical asthma symptom control. Users will also find an
    ​RCGP-accredited CME activity worth 1 CME credit.

Latest News

FDA grants accelerated approval for Keytruda (pembrolizumab) to treat squamous and non squamous NSCLC-Merck Inc.


Merck announced that the FDA has on 2 October 2015, approved Keytruda (pembrolizumab) monotherapy, the company’s anti-PD-1 (programmed death receptor-1) therapy, at a dose of 2 mg/kg every three weeks, for the treatment of patients with metastatic ...

FDA approves combination of Letairis (ambrisentan) and Adcirca (tadalafil) in pulmonary arterial hypertension- Gilead Sciences


The FDA has approved the use of Letairis (ambrisentan), from Gilead Sciences, in combination with Adcirca (tadalafil) for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to reduce the risks of disease progression and ...

FDA approves PD-L1 IHC 22C3 pharmDx assay, a Keytruda companion diagnostic, for non-small cell lung cancer patients-Dako


The FDA has approved a companion diagnostic, the PD-L1 IHC 22C3 pharmDx assay, from Dako, an Agilent Technologies company, to assess the eligibility of non-small cell lung cancer patients for treatment with Keytruda (pembrolizumab), from Merck Inc. ...

Sandoz files BLA at FDA for etanercept biosimilar .


Sandoz, a Novartis company and the global leader in biosimilars, announced that the FDA has accepted its Biologics License Application (BLA) under the 351 (k) pathway for its proposed biosimilar to Amgen's US-licensed Enbrel (etanercept) - a tumor ...

UX 001 (aceneuramic acid prolonged release) filed with EU for hereditary inclusion body myopathy-Ultragenyx Pharmaceutical


Ultragenyx Pharmaceutical has successfully filed a Marketing Authorization Application with the European Medicines Agency for UX 001 tablets (aceneuramic acid prolonged release) intended for patients with GNE Myopathy. UX 001 is designed to replace ...

Xeomin (incobotulinumtoxinA) filed with FDA for treatment of upper limb spasticity- Merz


Merz Neurosciences, a division of Merz North America, has submitted an sBLA to the FDA to seek approval for the use of Xeomin (incobotulinumtoxinA) in the treatment of upper limb spasticity. In addition, data from the open-label extension of its ...

Bedwetting resource receives a mobile-friendly transformation


The Bedwetting Knowledge Centre has recently been modernised with a mobile-responsive design. Users of EPGonline.org will now be able to easily explore this FREE resource on their mobile and tablet devices. Existing sections include a Disease ...

Recent Updates


Clinical Guidelines

Management of Obesity in Adults: European Clinical Practice Guidelines

British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia

Guidelines on the measurement of ultraviolet radiation levels in ultraviolet phototherapy: report issued by the British Association of Dermatologists and British Photodermatology Group 2015

Coeliac disease: recognition, assessment and management

Medical Journals

Amantadine in Parkinson's disease.

Pharmacological treatment of Parkinson disease: a review.

Management of Parkinson׳s disease: Current and future pharmacotherapy.

Deep-brain stimulation – entering the era of human neural-network modulation.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors